Related Experiment Video
Updated: Jan 31, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
Apixaban-induced liver injury
Salvador Machlab1, Mireia Miquel2, Mercedes Vergara2
1Servicio de Aparato Digestivo, Corporació Sanitària Universitària Parc Taulí. Universitat Autònoma de Barcelona, España.
Abstract:
The use of new oral anticoagulants such as apixaban is increasing. We present the case of an 85-year-old patient who was diagnosed with mixed profile toxic hepatitis due to apixaban use. An etiological study was negative, except for anti-smooth muscle antibodies, and a liver biopsy ruled out autoimmune hepatitis. The patient was assigned a score of 7 on the CIOMS/RUCAM scale, indicating a probable causality. The liver injury improved after the withdrawal of apixaban. A previous meta-analysis reported that the risk of hepatotoxicity does not increase with the use of apixaban, nor were any cases reported in registry studies. Nonetheless, more than 120 possible cases currently appear in the European pharmacovigilance database (EudraVigilance). We suggest that apixaban should be considered as a possible cause of liver injury.
Insights
New oral anticoagulants like apixaban can cause drug-induced liver injury. This case study highlights a probable link between apixaban and toxic hepatitis, emphasizing the need for vigilance.
Area of Science:
- Hepatology
- Pharmacovigilance
- Internal Medicine
Background:
- New oral anticoagulants (NOACs), including apixaban, are increasingly prescribed for anticoagulation.
- While generally considered safe, potential adverse drug reactions require ongoing monitoring.
- Drug-induced liver injury (DILI) is a significant concern with various medications.
Observation:
- An 85-year-old patient developed mixed-profile toxic hepatitis.
- Apixaban was identified as the likely causative agent based on clinical presentation and causality assessment (CIOMS/RUCAM score of 7).
- Liver biopsy excluded autoimmune hepatitis, and other etiological factors were ruled out.
Findings:
- The patient's liver injury significantly improved after discontinuing apixaban.
- Despite a previous meta-analysis suggesting no increased risk of hepatotoxicity with apixaban, over 120 potential cases are reported in EudraVigilance.
- This case suggests a probable causal relationship between apixaban and liver injury.
Implications:
- Apixaban should be considered a potential cause of drug-induced liver injury.
- Clinicians should maintain a high index of suspicion for hepatotoxicity in patients taking apixaban.
- Further pharmacovigilance studies are warranted to fully elucidate the risk of apixaban-associated liver injury.
Related Concept Videos
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Gross Anatomy of the Liver
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...

